香港潮商集團(02322.HK)擬折讓7.41%配售4.4億股籌資2.14億港元
格隆匯12月2日丨香港潮商集團(02322.HK)公佈,於2019年12月2日,配售代理與公司訂立配售協議,公司擬配售最多4.4億股,相當於公司現有已發行股本約11.95%及經配發擴大已發行股本約10.68%。配售價每股配售股份0.50港元,較12月2日收市價每股0.54港元折讓約7.41%。
預期配售事項所得款項淨額約2.14億港元,其中2.04億港元擬用作償付公司就收購事項應付的部分代價,而餘額約1010萬港元將用作該集團的一般營運資金。
董事認為,配售事項乃為公司籌集額外資金的機會,以於與其他集資方法比較相對較短時間內及按較低成本償付應付代價而並不增加其債務及任何利息負擔,並擴大該公司的股東基礎,從而可提升股份的流動性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.